Maternal Immune Activation and Autism Spectrum Disorder: From Rodents to Nonhuman and Human Primates

Biological Psychiatry

Volumn 81, Issue 5, 2017, Pages 391-401

  Careaga, Milo ^a,b   Murai, Takeshi ^a,c,d   Bauman, Melissa D ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Animal model; Autism; Neuroimmunology; Prenatal; Risk factor; Schizophrenia

Indexed keywords

CYTOKINE; POLYCYTIDYLIC ACID;

AUTISM; BEHAVIOR; BRAIN DEVELOPMENT; CENTRAL NERVOUS SYSTEM DISEASE; HUMAN; IMMUNE RESPONSE; INFECTION; MATERNAL IMMUNE ACTIVATION; MATERNAL INFECTION; NONHUMAN; PHENOTYPE; PREDICTIVE VALIDITY; PRIMATE; PRIORITY JOURNAL; PROGENY; REVIEW; RODENT; ANIMAL; AUTISM SPECTRUM DISORDER; BRAIN; DISEASE MODEL; FEMALE; FETOMATERNAL TRANSFUSION; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; MOUSE; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; RAT; RHESUS MONKEY; RISK FACTOR;

ANIMALS; AUTISM SPECTRUM DISORDER; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MACACA MULATTA; MATERNAL-FETAL EXCHANGE; MICE; POLY C; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RISK FACTORS;

EID: 85010917026     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2016.10.020     Document Type: Review

References (146)

1. 1 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed., 2013, American Psychiatric Press, Washington, DC.
2. 2 Estes, M.L., McAllister, A.K., Immune mediators in the brain and peripheral tissues in autism spectrum disorder. Nat Rev Neurosci 16 (2015), 469–486.
3. 3 Fox-Edmiston, E., Van de Water, J., Maternal anti-fetal brain IgG autoantibodies and autism spectrum disorder: Current knowledge and its implications for potential therapeutics. CNS Drugs 29 (2015), 715–724.
4. 4 Patterson, P.H., Maternal infection and immune involvement in autism. Trends Mol Med 17 (2011), 389–394.
5. 5 Deverman, B.E., Patterson, P.H., Cytokines and CNS development. Neuron 64 (2009), 61–78.
6. 6 Garay, P.A., McAllister, A.K., Novel roles for immune molecules in neural development: Implications for neurodevelopmental disorders. Front Synaptic Neurosci, 2, 2010, 136.
7. 7 Estes, M.L., McAllister, A.K., Maternal immune activation: Implications for neuropsychiatric disorders. Science 353 (2016), 772–777.
8. 8 Knuesel, I., Chicha, L., Britschgi, M., Schobel, S.A., Bodmer, M., Hellings, J.A., et al. Maternal immune activation and abnormal brain development across CNS disorders. Nat Rev Neurol 10 (2014), 643–660.
9. 9 Ciaranello, A.L., Ciaranello, R.D., The neurobiology of infantile autism. Annu Rev Neurosci 18 (1995), 101–128.
10. 10 Libbey, J.E., Sweeten, T.L., McMahon, W.M., Fujinami, R.S., Autistic disorder and viral infections. J Neurovirol 11 (2005), 1–10.
11. 11 Parker-Athill, E.C., Tan, J., Maternal immune activation and autism spectrum disorder: Interleukin-6 signaling as a key mechanistic pathway. Neuro-Signals 18 (2010), 113–128.
12. 12 Dassa, D., Takei, N., Sham, P.C., Murray, R.M., No association between prenatal exposure to influenza and autism. Acta Psychiatr Scand 92 (1995), 145–149.
13. 13 Maimburg, R.D., Vaeth, M., Perinatal risk factors and infantile autism. Acta Psychiatr Scand 114 (2006), 257–264.
14. 14 Chess, S., Autism in children with congenital rubella. J Autism Childhood Schizophr 1 (1971), 33–47.
15. 15 Desmond, M.M., Wilson, G.S., Melnick, J.L., Singer, D.B., Zion, T.E., Rudolph, A.J., et al. Congenital rubella encephalitis. Course and early sequelae. J Pediatr 71 (1967), 311–331.
16. 16 Deykin, E.Y., MacMahon, B., Viral exposure and autism. Am J Epidemiol 109 (1979), 628–638.
17. 17 Ivarsson, S.A., Bjerre, I., Vegfors, P., Ahlfors, K., Autism as one of several disabilities in two children with congenital cytomegalovirus infection. Neuropediatrics 21 (1990), 102–103.
18. 18 Markowitz, P.I., Autism in a child with congenital cytomegalovirus infection. J Autism Dev Disord 13 (1983), 249–253.
19. 19 Sweeten, T.L., Posey, D.J., McDougle, C.J., Brief report: Autistic disorder in three children with cytomegalovirus infection. J Autism Dev Disord 34 (2004), 583–586.
20. 20 Atladottir, H.O., Thorsen, P., Ostergaard, L., Schendel, D.E., Lemcke, S., Abdallah, M., et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 40 (2010), 1423–1430.
21. 21 Atladóttir, H.Ó., Henriksen, T.B., Schendel, D.E., Parner, E.T., Autism after infection, febrile episodes, and antibiotic use during pregnancy: An exploratory study. Pediatrics 130 (2012), e1447–e1454.
22. 22 Zerbo, O., Iosif, A.M., Walker, C., Ozonoff, S., Hansen, R.L., Hertz-Picciotto, I., Is maternal influenza or fever during pregnancy associated with autism or developmental delays? Results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) study. J Autism Dev Disord 43 (2013), 25–33.
23. 23 Zerbo, O., Qian, Y., Yoshida, C., Grether, J.K., Van de Water, J., Croen, L.A., Maternal infection during pregnancy and autism spectrum disorders. J Autism Dev Disord 45 (2015), 4015–4025.
24. 24 Goines, P.E., Croen, L.A., Braunschweig, D., Yoshida, C.K., Grether, J., Hansen, R., et al. Increased midgestational IFN-gamma, IL-4 and IL-5 in women bearing a child with autism: A case-control study. Mol Autism, 2, 2011, 13.
25. 25 Jones, K.L., Croen, L.A., Yoshida, C.K., Heuer, L., Hansen, R., Zerbo, O., et al. Autism with intellectual disability is associated with increased levels of maternal cytokines and chemokines during gestation [published online ahead of print May 24]. Mol Psychiatry., 2016.
26. 26 Abdallah, M.W., Larsen, N., Grove, J., Nørgaard-Pedersen, B., Thorsen, P., Mortensen, E.L., et al. Amniotic fluid chemokines and autism spectrum disorders: An exploratory study utilizing a Danish Historic Birth Cohort. Brain Behav Immun 26 (2012), 170–176.
27. 27 Abdallah, M.W., Larsen, N., Grove, J., Nørgaard-Pedersen, B., Thorsen, P., Mortensen, E.L., et al. Amniotic fluid inflammatory cytokines: Potential markers of immunologic dysfunction in autism spectrum disorders. World J Biol Psychiatry 14 (2013), 528–538.
28. 28 Brown, A.S., Sourander, A., Hinkka-Yli-Salomaki, S., McKeague, I.W., Sundvall, J., Surcel, H.M., Elevated maternal C-reactive protein and autism in a national birth cohort. Mol Psychiatry 19 (2014), 259–264.
29. 29 Zerbo, O., Traglia, M., Yoshida, C., Heuer, L.S., Ashwood, P., Delorenze, G.N., et al. Maternal mid-pregnancy C-reactive protein and risk of autism spectrum disorders: The early markers for autism study. Transl Psychiatry, 6, 2016, e783.
30. 30 Brown, A.S., Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Dev Neurobiol 72 (2012), 1272–1276.
31. 31 Brown, A.S., Derkits, E.J., Prenatal infection and schizophrenia: A review of epidemiologic and translational studies. Am J Psychiatry 167 (2010), 261–280.
32. 32 Boksa, P., Effects of prenatal infection on brain development and behavior: A review of findings from animal models. Brain Behav Immun 24 (2010), 881–897.
33. 33 Meyer, U., Feldon, J., Fatemi, S.H., In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci Biobehav Rev, 33, 2009, 1061–1079.
34. 34 Patterson, P.H., Immune involvement in schizophrenia and autism: Etiology, pathology and animal models. Behav Brain Res 204 (2009), 313–321.
35. 35 Piontkewitz, Y., Arad, M., Weiner, I., Tracing the development of psychosis and its prevention: What can be learned from animal models. Neuropharmacology 62 (2012), 1273–1289.
36. 36 Medzhitov, R., Toll-like receptors and innate immunity. Nat Rev Immunol 1 (2001), 135–145.
37. 37 Meyer, U., Feldon, J., To poly(I:C) or not to poly(I:C): Advancing preclinical schizophrenia research through the use of prenatal immune activation models. Neuropharmacology 62 (2012), 1308–1321.
38. 38 Harvey, L., Boksa, P., Prenatal and postnatal animal models of immune activation: Relevance to a range of neurodevelopmental disorders. Dev Neurobiol 72 (2012), 1335–1348.
39. 39 Meyer, U., Feldon, J., Dammann, O., Schizophrenia and autism: Both shared and disorder-specific pathogenesis via perinatal inflammation?. Pediatr Res 69 (2011), 26R–33R.
40. 40 Meyer, U., Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems. Biol Psychiatry 75 (2014), 307–315.
41. 41 Nestler, E.J., Hyman, S.E., Animal models of neuropsychiatric disorders. Nat Neurosci 13 (2010), 1161–1169.
42. 42 Patterson, P.H., Modeling autistic features in animals. Pediatr Res 69 (2011), 34R–40R.
43. 43 Tordjman, S., Drapier, D., Bonnot, O., Graignic, R., Fortes, S., Cohen, D., et al. Animal models relevant to schizophrenia and autism: Validity and limitations. Behav Genet 37 (2007), 61–78.
44. 44 Willner, P., The validity of animal models of depression. Psychopharmacology 83 (1984), 1–16.
45. 45 Silverman, J.L., Yang, M., Lord, C., Crawley, J.N., Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci 11 (2010), 490–502.
46. 46 Cuthbert, B.N., Insel, T.R., Toward the future of psychiatric diagnosis: The seven pillars of RDoC. BMC Med, 11, 2013, 126.
47. 47 Casey, B.J., Oliveri, M.E., Insel, T., A neurodevelopmental perspective on the research domain criteria (RDoC) framework. Biol Psychiatry 76 (2014), 350–353.
48. 48 Cosgrove, V.E., Kelsoe, J.R., Suppes, T., Toward a valid animal model of bipolar disorder: How the research domain criteria help bridge the clinical-basic science divide. Biol Psychiatry 79 (2016), 62–70.
49. 49 Damiano, C.R., Mazefsky, C.A., White, S.W., Dichter, G.S., Future directions for research in autism spectrum disorders. J Clin Child Adolesc Psychol 43 (2014), 828–843.
50. 50 Stewart, A.M., Kalueff, A.V., Developing better and more valid animal models of brain disorders. Behav Brain Res 276 (2015), 28–31.
51. 51 Belzung, C., Lemoine, M., Criteria of validity for animal models of psychiatric disorders: Focus on anxiety disorders and depression. Biol Mood Anxiety Disord, 1, 2011, 9.
52. 52 Vanderschuren, L.J., Trezza, V., What the laboratory rat has taught us about social play behavior: Role in behavioral development and neural mechanisms. Curr Top Behav Neurosci 16 (2014), 189–212.
53. 53 Couture, S.M., Penn, D.L., Losh, M., Adolphs, R., Hurley, R., Piven, J., Comparison of social cognitive functioning in schizophrenia and high functioning autism: More convergence than divergence. Psychol Med 40 (2010), 569–579.
54. 54 Chang, S.W., Brent, L.J., Adams, G.K., Klein, J.T., Pearson, J.M., Watson, K.K., et al. Neuroethology of primate social behavior. Proc Natl Acad Sci U S A 110:suppl 2 (2013), 10387–10394.
55. 55 Platt, M.L., Seyfarth, R.M., Cheney, D.L., Adaptations for social cognition in the primate brain. Philos Trans R Soc Lond B Biol Sci, 371, 2016, 20150096.
56. 56 Preuss, T., Do rats have a prefrontal cortex? The Rose-Woolsey-Akert reconsidered. J Cogn Neurosci 7 (1995), 1–24.
57. 57 Watson, K.K., Platt, M.L., Of mice and monkeys: Using non-human primate models to bridge mouse- and human-based investigations of autism spectrum disorders. J Neurodev Disord, 4, 2012, 21.
58. 58 Lord, C., Bishop, S.L., Recent advances in autism research as reflected in DSM-5 criteria for autism spectrum disorder. Annu Rev Clin Psychol 11 (2015), 53–70.
59. 59 Peters, S.M., Pothuizen, H.H., Spruijt, B.M., Ethological concepts enhance the translational value of animal models. Eur J Pharmacol 759 (2015), 42–50.
60. 60 Choi, G.B., Yim, Y.S., Wong, H., Kim, S., Kim, H., Kim, S.V., et al. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science 351 (2016), 933–939.
61. 61 Schwartzer, J.J., Careaga, M., Onore, C.E., Rushakoff, J.A., Berman, R.F., Ashwood, P., Maternal immune activation and strain specific interactions in the development of autism-like behaviors in mice. Transl Psychiatry, 3, 2013, e240.
62. 62 Hsiao, E.Y., McBride, S.W., Hsien, S., Sharon, G., Hyde, E.R., McCue, T., et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155 (2013), 1451–1463.
63. 63 Malkova, N.V., Collin, Z.Y., Hsiao, E.Y., Moore, M.J., Patterson, P.H., Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav Immun 26 (2012), 607–616.
64. 64 Yang, M, Silverman, JL, Crawley, JN, Automated three-chambered social approach task for mice. Curr Protoc Neurosci Chapter 8, 2011 Unit 826.
65. 65 Aavani, T., Rana, S.A., Hawkes, R., Pittman, Q.J., Maternal immune activation produces cerebellar hyperplasia and alterations in motor and social behaviors in male and female mice. Cerebellum 14 (2015), 491–505.
66. 66 Abazyan, B., Nomura, J., Kannan, G., Ishizuka, K., Tamashiro, K.L., Nucifora, F., et al. Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology. Biol Psychiatry 68 (2010), 1172–1181.
67. 67 Bitanihirwe, B.K., Peleg-Raibstein, D., Mouttet, F., Feldon, J., Meyer, U., Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia. Neuropsychopharmacology 35 (2010), 2462–2478.
68. 68 Hsiao, E.Y., McBride, S.W., Chow, J., Mazmanian, S.K., Patterson, P.H., Modeling an autism risk factor in mice leads to permanent immune dysregulation. Proc Natl Acad Sci U S A 109 (2012), 12776–12781.
69. 69 Naviaux, R.K., Zolkipli, Z., Wang, L., Nakayama, T., Naviaux, J.C., Le, T.P., et al. Antipurinergic therapy corrects the autism-like features in the poly (IC) mouse model. PloS One, 8, 2013, e57380.
70. 70 Naviaux, J., Schuchbauer, M., Li, K., Wang, L., Risbrough, V., Powell, S., et al. Reversal of autism-like behaviors and metabolism in adult mice with single-dose antipurinergic therapy. Transl Psychiatry, 4, 2014, e400.
71. 71 Pineda, E., Shin, D., You, S.J., Auvin, S., Sankar, R., Mazarati, A., Maternal immune activation promotes hippocampal kindling epileptogenesis in mice. Ann Neurol 74 (2013), 11–19.
72. 72 Smith, S.E., Li, J., Garbett, K., Mirnics, K., Patterson, P.H., Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 27 (2007), 10695–10702.
73. 73 Zhu, F., Zheng, Y., Liu, Y., Zhang, X., Zhao, J., Minocycline alleviates behavioral deficits and inhibits microglial activation in the offspring of pregnant mice after administration of polyriboinosinic-polyribocytidilic acid. Psychiatry Res 219 (2014), 680–686.
74. 74 Ku, K.M., Weir, R.K., Silverman, J.L., Berman, R.F., Bauman, M.D., Behavioral phenotyping of juvenile Long-Evans and Sprague-Dawley rats: Implications for preclinical models of autism spectrum disorders. PLoS One, 11, 2016, e0158150.
75. 75 Yee, N., Schwarting, R.K., Fuchs, E., Wohr, M., Increased affective ultrasonic communication during fear learning in adult male rats exposed to maternal immune activation. J Psychiatr Res 46 (2012), 1199–1205.
76. 76 Bauman, M.D., Iosif, A.M., Smith, S.E., Bregere, C., Amaral, D.G., Patterson, P.H., Activation of the maternal immune system during pregnancy alters behavioral development of rhesus monkey offspring. Biol Psychiatry 75 (2014), 332–341.
77. 77 Petkov, C.I., Kayser, C., Steudel, T., Whittingstall, K., Augath, M., Logothetis, N.K., A voice region in the monkey brain. Nat Neurosci 11 (2008), 367–374.
78. 78 Machado, C.J., Whitaker, A.M., Smith, S.E., Patterson, P.H., Bauman, M.D., Maternal immune activation in nonhuman primates alters social attention in juvenile offspring. Biol Psychiatry 77 (2015), 823–832.
79. 79 Pelphrey, K.A., Sasson, N.J., Reznick, J.S., Paul, G., Goldman, B.D., Piven, J., Visual scanning of faces in autism. J Autism Dev Disord 32 (2002), 249–261.
80. 80 Toh, W.L., Rossell, S.L., Castle, D.J., Current visual scanpath research: A review of investigations into the psychotic, anxiety, and mood disorders. Compr Psychiatry 52 (2011), 567–579.
81. 81 Kas, M.J., Glennon, J.C., Buitelaar, J., Ey, E., Biemans, B., Crawley, J., et al. Assessing behavioural and cognitive domains of autism spectrum disorders in rodents: Current status and future perspectives. Psychopharmacology 231 (2014), 1125–1146.
82. 82 Meyer, U., Feldon, J., Schedlowski, M., Yee, B.K., Toward an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev 29 (2005), 913–947.
83. 83 Meyer, U., Nyffeler, M., Engler, A., Urwyler, A., Schedlowski, M., Knuesel, I., et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 26 (2006), 4752–4762.
84. 84 Han, X., Li, N., Meng, Q., Shao, F., Wang, W., Maternal immune activation impairs reversal learning and increases serum tumor necrosis factor-alpha in offspring. Neuropsychobiology 64 (2011), 9–14.
85. 85 Wolff, A.R., Cheyne, K.R., Bilkey, D.K., Behavioural deficits associated with maternal immune activation in the rat model of schizophrenia. Behav Brain Res 225 (2011), 382–387.
86. 86 Zuckerman, L., Weiner, I., Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J Psychiatr Res 39 (2005), 311–323.
87. 87 Ecker, C., Murphy, D., Neuroimaging in autism–From basic science to translational research. Nat Rev Neurol 10 (2014), 82–91.
88. 88 Amaral, D.G., Schumann, C.M., Nordahl, C.W., Neuroanatomy of autism. Trends Neurosci 31 (2008), 137–145.
89. 89 Courchesne, E., Redcay, E., Kennedy, D.P., The autistic brain: Birth through adulthood. Curr Opin Neurol 17 (2004), 489–496.
90. 90 Shi, L., Smith, S.E., Malkova, N., Tse, D., Su, Y., Patterson, P.H., Activation of the maternal immune system alters cerebellar development in the offspring. Brain Behav Immun 23 (2009), 116–123.
91. 91 Hampson, D.R., Blatt, G.J., Autism spectrum disorders and neuropathology of the cerebellum. Front Neurosci, 9, 2015, 420.
92. 92 Giovanoli, S., Weber, L., Meyer, U., Single and combined effects of prenatal immune activation and peripubertal stress on parvalbumin and reelin expression in the hippocampal formation. Brain Behav Immun 40 (2014), 48–54.
93. 93 Meyer, U., Nyffeler, M., Yee, B.K., Knuesel, I., Feldon, J., Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun 22 (2008), 469–486.
94. 94 Folsom, T.D., Fatemi, S.H., The involvement of reelin in neurodevelopmental disorders. Neuropharmacology 68 (2013), 122–135.
95. 95 Morgan, J.T., Chana, G., Pardo, C.A., Achim, C., Semendeferi, K., Buckwalter, J., et al. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol Psychiatry 68 (2010), 368–376.
96. 96 Morgan, J.T., Chana, G., Abramson, I., Semendeferi, K., Courchesne, E., Everall, I.P., Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autism. Brain Res 1456 (2012), 72–81.
97. 97 Morgan, J.T., Barger, N., Amaral, D.G., Schumann, C.M., Stereological study of amygdala glial populations in adolescents and adults with autism spectrum disorder. PLoS One, 9, 2014, e110356.
98. 98 Tetreault, N.A., Hakeem, A.Y., Jiang, S., Williams, B.A., Allman, E., Wold, B.J., et al. Microglia in the cerebral cortex in autism. J Autism Dev Disord 42 (2012), 2569–2584.
99. 99 Vargas, D.L., Nascimbene, C., Krishnan, C., Zimmerman, A.W., Pardo, C.A., Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57 (2005), 67–81.
100. 100 Juckel, G., Manitz, M.P., Brune, M., Friebe, A., Heneka, M.T., Wolf, R.J., Microglial activation in a neuroinflammational animal model of schizophrenia–A pilot study. Schizophr Res 131 (2011), 96–100.
101. 101 Van den Eynde, K., Missault, S., Fransen, E., Raeymaekers, L., Willems, R., Drinkenburg, W., et al. Hypolocomotive behaviour associated with increased microglia in a prenatal immune activation model with relevance to schizophrenia. Behav Brain Res 258 (2014), 179–186.
102. 102 Garay, P.A., Hsiao, E.Y., Patterson, P.H., McAllister, A.K., Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development. Brain Behav Immun 31 (2012), 54–68.
103. 103 Giovanoli, S., Notter, T., Richetto, J., Labouesse, M.A., Vuillermot, S., Riva, M.A., et al. Late prenatal immune activation causes hippocampal deficits in the absence of persistent inflammation across aging. J Neuroinflammation, 12, 2015, 221.
104. 104 Mattei, D., Djodari-Irani, A., Hadar, R., Pelz, A., de Cossio, L.F., Goetz, T., et al. Minocycline rescues decrease in neurogenesis, increase in microglia cytokines and deficits in sensorimotor gating in an animal model of schizophrenia. Brain Behav Immun 38 (2014), 175–184.
105. 105 Missault, S., Van den Eynde, K., Vanden Berghe, W., Fransen, E., Weeren, A., Timmermans, J.P., et al. The risk for behavioural deficits is determined by the maternal immune response to prenatal immune challenge in a neurodevelopmental model. Brain Behav Immun 42 (2014), 138–146.
106. 106 Piontkewitz, Y., Bernstein, H.G., Dobrowolny, H., Bogerts, B., Weiner, I., Keilhoff, G., Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats. Brain Behav Immun 26 (2012), 353–363.
107. 107 Smolders, S., Smolders, S.M., Swinnen, N., Gartner, A., Rigo, J.M., Legendre, P., et al. Maternal immune activation evoked by polyinosinic:polycytidylic acid does not evoke microglial cell activation in the embryo. Front Cell Neurosci, 9, 2015, 301.
108. 108 Pratt, L., Ni, L., Ponzio, N.M., Jonakait, G.M., Maternal inflammation promotes fetal microglial activation and increased cholinergic expression in the fetal basal forebrain: Role of interleukin-6. Pediatr Res 74 (2013), 393–401.
109. 109 Weir, R.K., Forghany, R., Smith, S.E., Patterson, P.H., McAllister, A.K., Schumann, C.M., et al. Preliminary evidence of neuropathology in nonhuman primates prenatally exposed to maternal immune activation. Brain Behav Immun 48 (2015), 139–146.
110. 110 Meyer, U., Spoerri, E., Yee, B.K., Schwarz, M.J., Feldon, J., Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia. Schizophr Bull 36 (2010), 607–623.
111. 111 Piontkewitz, Y., Assaf, Y., Weiner, I., Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia. Biol Psychiatry 66 (2009), 1038–1046.
112. 112 Piontkewitz, Y., Arad, M., Weiner, I., Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia. Schizophr Bull 37 (2011), 1257–1269.
113. 113 Liu, C.C., Demjaha, A., Antipsychotic interventions in prodromal psychosis: Safety issues. CNS Drugs 27 (2013), 197–205.
114. 114 Boris, M., Kaiser, C.C., Goldblatt, A., Elice, M.W., Edelson, S.M., Adams, J.B., et al. Effect of pioglitazone treatment on behavioral symptoms in autistic children. J Neuroinflammation, 4, 2007, 3.
115. 115 De Miranda, J., Yaddanapudi, K., Hornig, M., Villar, G., Serge, R., Lipkin, W.I., Induction of Toll-like receptor 3-mediated immunity during gestation inhibits cortical neurogenesis and causes behavioral disturbances. MBio 1 (2010), e00176–10.
116. 116 Fortier, M.E., Luheshi, G.N., Boksa, P., Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of the infectious agent and the stage of pregnancy. Behav Brain Res 181 (2007), 270–277.
117. 117 Garbett, K.A., Hsiao, E.Y., Kalman, S., Patterson, P.H., Mirnics, K., Effects of maternal immune activation on gene expression patterns in the fetal brain. Transl Psychiatry, 2, 2012, e98.
118. 118 Collins, F.S., Tabak, L.A., Policy: NIH plans to enhance reproducibility. Nature 505 (2014), 612–613.
119. 119 Landis, S.C., Amara, S.G., Asadullah, K., Austin, C.P., Blumenstein, R., Bradley, E.W., et al. A call for transparent reporting to optimize the predictive value of preclinical research. Nature 490 (2012), 187–191.
120. 120 Kilkenny, C., Browne, W.J., Cuthill, I.C., Emerson, M., Altman, D.G., Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. PLoS Biol, 8, 2010, e1000412.
121. 121 Shi, L., Fatemi, S.H., Sidwell, R.W., Patterson, P.H., Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 23 (2003), 297–302.
122. 122 Arad, M., Atzil, S., Shakhar, K., Adoni, A., Ben-Eliyahu, S., Poly I-C induces early embryo loss in f344 rats: A potential role for NK cells. Am J Reprod Immunol 54 (2005), 49–53.
123. 123 Goeden, N., Velasquez, J., Arnold, K.A., Chan, Y., Lund, B.T., Anderson, G.M., et al. Maternal inflammation disrupts fetal neurodevelopment via increased placental output of serotonin to the fetal brain. J Neurosci 36 (2016), 6041–6049.
124. 124 Mian, M.F., Ahmed, A.N., Rad, M., Babaian, A., Bowdish, D., Ashkar, A.A., Length of dsRNA (poly I:C) drives distinct innate immune responses, depending on the cell type. J Leukoc Biol 94 (2013), 1025–1036.
125. 125 Zhou, Y., Guo, M., Wang, X., Li, J., Wang, Y., Ye, L., et al. TLR3 activation efficiency by high or low molecular mass poly I:C. Innate Immun 19 (2013), 184–192.
126. 126 Bauman, M., Careaga, M., Chang, C., Chiang, A., Ku, K., Berman, R.F., PolyI:C response is dependent on length: Implications for preclinical maternal immune activation models [abstract]. Biol Psychiatry, 79(9S), 2016, 60S.
127. 127 Harvey, L., Boksa, P., A stereological comparison of GAD67 and reelin expression in the hippocampal stratum oriens of offspring from two mouse models of maternal inflammation during pregnancy. Neuropharmacology 62 (2012), 1767–1776.
128. 128 Ballendine, S.A., Greba, Q., Dawicki, W., Zhang, X., Gordon, J.R., Howland, J.G., Behavioral alterations in rat offspring following maternal immune activation and ELR-CXC chemokine receptor antagonism during pregnancy: Implications for neurodevelopmental psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 57 (2015), 155–165.
129. 129 Connor, C.M., Dincer, A., Straubhaar, J., Galler, J.R., Houston, I.B., Akbarian, S., Maternal immune activation alters behavior in adult offspring, with subtle changes in the cortical transcriptome and epigenome. Schizophr Res 140 (2012), 175–184.
130. 130 Meyer, U., Feldon, J., Schedlowski, M., Yee, B.K., Immunological stress at the maternal-foetal interface: A link between neurodevelopment and adult psychopathology. Brain Behav Immun 20 (2006), 378–388.
131. 131 Meyer, U., Murray, P.J., Urwyler, A., Yee, B.K., Schedlowski, M., Feldon, J., Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol Psychiatry 13 (2008), 208–221.
132. 132 Vuillermot, S., Joodmardi, E., Perlmann, T., Ogren, S.O., Feldon, J., Meyer, U., Prenatal immune activation interacts with genetic Nurr1 deficiency in the development of attentional impairments. J Neurosci 32 (2012), 436–451.
133. 133 Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331 (2011), 337–341.
134. 134 Meyer, U., Yee, B.K., Feldon, J., The neurodevelopmental impact of prenatal infections at different times of pregnancy: The earlier the worse?. Neuroscientist 13 (2007), 241–256.
135. 135 Clancy, B., Darlington, R.B., Finlay, B.L., Translating developmental time across mammalian species. Neuroscience 105 (2001), 7–17.
136. 136 Rakic, P., Evolution of the neocortex: A perspective from developmental biology. Nat Rev Neurosci 10 (2009), 724–735.
137. 137 Thompson, B.L., Levitt, P., Stanwood, G.D., Prenatal exposure to drugs: Effects on brain development and implications for policy and education. Nat Rev Neurosci 10 (2009), 303–312.
138. 138 Lipina, T.V., Zai, C., Hlousek, D., Roder, J.C., Wong, A.H., Maternal immune activation during gestation interacts with Disc1 point mutation to exacerbate schizophrenia-related behaviors in mice. J Neurosci 33 (2013), 7654–7666.
139. 139 Wu, W.L., Adams, C.E., Stevens, K.E., Chow, K.H., Freedman, R., Patterson, P.H., The interaction between maternal immune activation and alpha 7 nicotinic acetylcholine receptor in regulating behaviors in the offspring. Brain Behav Immun 46 (2015), 192–202.
140. 140 Ehninger, D., Sano, Y., de Vries, P.J., Dies, K., Franz, D., Geschwind, D.H., et al. Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice. Mol Psychiatry 17 (2012), 62–70.
141. 141 Meyer, U., Nyffeler, M., Schwendener, S., Knuesel, I., Yee, B.K., Feldon, J., Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology 33 (2008), 441–456.
142. 142 Richetto, J., Calabrese, F., Meyer, U., Riva, M.A., Prenatal versus postnatal maternal factors in the development of infection-induced working memory impairments in mice. Brain Behav Immun 33 (2013), 190–200.
143. 143 Schwendener, S., Meyer, U., Feldon, J., Deficient maternal care resulting from immunological stress during pregnancy is associated with a sex-dependent enhancement of conditioned fear in the offspring. J Neurodev Disord 1 (2009), 15–32.
144. 144 Giovanoli, S., Engler, H., Engler, A., Richetto, J., Voget, M., Willi, R., et al. Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science 339 (2013), 1095–1099.
145. 145 Yee, N., Ribic, A., de Roo, C.C., Fuchs, E., Differential effects of maternal immune activation and juvenile stress on anxiety-like behaviour and physiology in adult rats: no evidence for the “double-hit hypothesis”. Behav Brain Res 224 (2011), 180–188.
146. 146 Bauman, M.D., Schumann, C.M., Is ׳bench-to-bedside׳ realistic for autism? An integrative neuroscience approach. Neuropsychiatry (London) 3 (2013), 159–168.